[(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate

C35H44N2O9 — CID 15966778

IUPAC[(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
SMILESCOc1ccccc1C1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O
InChIInChI=1S/C35H44N2O9/c1-19-15-24-30(23-12-8-9-13-27(23)43-5)26(38)18-25(32(24)40)37-34(41)20(2)11-10-14-28(44-6)33(46-35(36)42)22(4)17-21(3)31(39)29(16-19)45-7/h8-14,17-19,21,28-29,31,33,39H,15-16H2,1-7H3,(H2,36,42)(H,37,41)/b14-10-,20-11+,22-17+/t19-,21+,28+,29+,31-,33-/m1/s1
InChIKeyUGCGGNKSABDKMQ-DTJZKZIWSA-N
MW636.74 g/mol
LogP3.97
Rot. Bonds5

About [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate

[(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate (PubChem CID 15966778) has the molecular formula C35H44N2O9 and a molecular weight of 636.74 g/mol. Its IUPAC name is [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate.

Molecular Properties

Compound Name[(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
PubChem CID15966778
Molecular FormulaC35H44N2O9
Molecular Weight636.74 g/mol
Exact Mass636.30
IUPAC Name[(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
SMILESCOc1ccccc1C1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O
InChIInChI=1S/C35H44N2O9/c1-19-15-24-30(23-12-8-9-13-27(23)43-5)26(38)18-25(32(24)40)37-34(41)20(2)11-10-14-28(44-6)33(46-35(36)42)22(4)17-21(3)31(39)29(16-19)45-7/h8-14,17-19,21,28-29,31,33,39H,15-16H2,1-7H3,(H2,36,42)(H,37,41)/b14-10-,20-11+,22-17+/t19-,21+,28+,29+,31-,33-/m1/s1
InChIKeyUGCGGNKSABDKMQ-DTJZKZIWSA-N
XLogP3.97
TPSA163.48 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500636.74
LogP ≤ 53.97
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'chinone_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
The IUPAC name of [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate (CID 15966778) is [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate.
What is the SMILES notation for [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
The canonical SMILES for [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate is COc1ccccc1C1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O.
What is the InChIKey of [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
The InChIKey is UGCGGNKSABDKMQ-DTJZKZIWSA-N. The full InChI is InChI=1S/C35H44N2O9/c1-19-15-24-30(23-12-8-9-13-27(23)43-5)26(38)18-25(32(24)40)37-34(41)20(2)11-10-14-28(44-6)33(46-35(36)42)22(4)17-21(3)31(39)29(16-19)45-7/h8-14,17-19,21,28-29,31,33,39H,15-16H2,1-7H3,(H2,36,42)(H,37,41)/b14-10-,20-11+,22-17+/t19-,21+,28+,29+,31-,33-/m1/s1.
What are the key properties of [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
[(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate has a molecular weight of 636.74 g/mol, XLogP of 3.97, 5 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(4E,6Z,8S,9R,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-19-(2-methoxyphenyl)-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate is sourced from PubChem (CID 15966778), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).